市場調查報告書

POC心臟檢查裝置的全球市場

Cardiac POC Testing Devices

出版商 Global Industry Analysts, Inc. 商品編碼 957677
出版日期 內容資訊 英文 128 Pages
商品交期: 最快1-2個工作天內
價格
POC心臟檢查裝置的全球市場 Cardiac POC Testing Devices
出版日期: 2020年09月01日內容資訊: 英文 128 Pages
簡介

全球POC心臟檢查裝置的市場規模在2020年∼2027年的分析期間中預計將以5.7%的年複合成長率增長,從2020年的27億美元到2027年達到39億美元。本報告所分析的市場區隔之一的心臟標記檢驗部門在分析期間結束前預測將以5.9%的年率增長,達到29億美元的規模。

本報告提供全球POC心臟檢查裝置市場的相關調查,提供市場佔有率,趨勢和預測,成長要素,各地區的市場分析,競爭情形,主要企業的簡介等資訊。

調查對象企業範例

  • Abbott Laboratories
  • BG Medicine, Inc.
  • LifeSign LLC.
  • Medtronic PLC
  • Nexus-Dx.
  • Roche Diagnostics
  • Siemens Healthineers

目錄

I. 簡介,調查手法,調查範圍

II. 摘要整理

  • 市場概要
    • 競爭的市場佔有率
    • 競爭的市場佔有率方案
    • Covid-19的影響和即將到來的全球景氣衰退
  • 主要企業
  • 趨勢與成長要素
  • 全球市場預測

III. 市場分析

  • 各地區市場分析
  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 其他地區

IV. 競爭

  • 企業簡介:44公司

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP10897

Global Cardiac POC Testing Devices Market to Reach $3.9 Billion by 2027

Amid the COVID-19 crisis, the global market for Cardiac POC Testing Devices estimated at US$2.7 Billion in the year 2020, is projected to reach a revised size of US$3.9 Billion by 2027, growing at aCAGR of 5.7% over the period 2020-2027. Cardiac Markers Test, one of the segments analyzed in the report, is projected to record 5.9% CAGR and reach US$2.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Analyzers segment is readjusted to a revised 5.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $782.6 Million, While China is Forecast to Grow at 5.3% CAGR

The Cardiac POC Testing Devices market in the U.S. is estimated at US$782.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$687.6 Million by the year 2027 trailing a CAGR of 5.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.4% and 4.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.We bring years of research experience to this 5th edition of our report. The 128-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abbott Laboratories
  • BG Medicine, Inc.
  • LifeSign LLC.
  • Medtronic PLC
  • Nexus-Dx.
  • Roche Diagnostics
  • Siemens Healthineers

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Global Competitor Market Shares
    • Cardiac POC Testing Devices Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Cardiac POC Testing Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 2: World Historic Review for Cardiac POC Testing Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 3: World 15-Year Perspective for Cardiac POC Testing Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Cardiac Markers Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 5: World Historic Review for Cardiac Markers Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 6: World 15-Year Perspective for Cardiac Markers Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 8: World Historic Review for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 9: World 15-Year Perspective for Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Cardiac POC Testing Devices Market Share (in %) by Company: 2019 & 2025
    • Market Analytics
    • TABLE 10: USA Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 11: USA Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 12: USA 15-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 13: Canada Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 14: Canada Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 15: Canada 15-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 16: Japan Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 17: Japan Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 18: Japan 15-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 19: China Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 20: China Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 21: China 15-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2012, 2020 & 2027
  • EUROPE
    • Market Facts & Figures
    • European Cardiac POC Testing Devices Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • Market Analytics
    • TABLE 22: Europe Current & Future Analysis for Cardiac POC Testing Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027
    • TABLE 23: Europe Historic Review for Cardiac POC Testing Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 24: Europe 15-Year Perspective for Cardiac POC Testing Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 25: Europe Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 26: Europe Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 27: Europe 15-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 28: France Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 29: France Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 30: France 15-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 31: Germany Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 32: Germany Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 33: Germany 15-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 34: Italy Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 35: Italy Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 36: Italy 15-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 37: UK Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 38: UK Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 39: UK 15-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 40: Rest of Europe Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 41: Rest of Europe Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 42: Rest of Europe 15-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 43: Asia-Pacific Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 44: Asia-Pacific Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 45: Asia-Pacific 15-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 46: Rest of World Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027
    • TABLE 47: Rest of World Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019
    • TABLE 48: Rest of World 15-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 44